Sartorius Aktiengesellschaft (VIE:SRT3)

Austria · Delayed Price · Currency is EUR · Preferred Stock

216.10

-3.00 (-1.37%)

At close: Jul 27, 2026

12.73% (1Y)

Market Cap	12.99B -7.4%
Revenue (ttm)	3.54B +4.7%
Net Income	154.90M +84.4%
EPS	2.24 +84.2%
Shares Out	n/a
PE Ratio	83.83
Forward PE	34.40
Dividend	0.74 (0.34%)
Ex-Dividend Date	Mar 27, 2026

Volume	n/a
Open	220.80
Previous Close	219.10
Day's Range	216.10 - 220.80
52-Week Range	177.10 - 266.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 23, 2026

About VIE:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture... [Read more]

Industry Laboratory Analytical Instruments

Founded 1870

Employees 14,242

Stock Exchange Vienna Stock Exchange

Ticker Symbol SRT3